• NeoGenomics held its annual shareholder meeting on May 21, 2026.
• Shareholders authorized a second amendment to the 2023 Equity Incentive Plan, expanding the share pool by 5 million shares; the filing reflects authorization, not issuance.
• Deloitte & Touche was ratified as independent registered public accountant.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-037735), on May 22, 2026, and is solely responsible for the information contained therein.